Blindness: Types, Causes, Treatment, and Prevention

Within the spectrum of ophthalmologic pathologies, two primary categories of glaucoma are distinguished: the open-angle variant and the angle-closure variant, which differ substantially in both their pathophysiological mechanisms and clinical presentations. In cases of acute angle-closure glaucoma (an ophthalmic emergency), patients experience severe ocular pain radiating to the frontal and temporal regions, often accompanied by episodes of nausea and vomiting. Concurrently, conjunctival hyperemia, corneal edema, and a marked elevation in intraocular pressure are observed. This condition necessitates immediate medical intervention to prevent permanent structural damage to the eye. It is important to note, however, that this form accounts for only approximately 10% of all glaucoma diagnoses within the European population. Far more prevalent—comprising roughly 90% of cases—is open-angle glaucoma, which is characterized by an insidious, asymptomatic progression over many years, gradually leading to irreversible degeneration of the optic nerve fibers. Given this asymptomatic nature, routine preventive examinations are of paramount importance, particularly for individuals over the age of 40, those with high-degree myopia, and those with a familial history of glaucoma.

The human eye continuously synthesizes aqueous humor, a transparent fluid essential for sustaining corneal and lenticular nutrition while facilitating the removal of metabolic byproducts. This fluid circulates into the anterior chamber of the eye, where it is subsequently drained into the venous system via the iridocorneal angle—an anatomical structure formed by the junction of the iris and cornea. The pathogenesis of glaucoma is fundamentally linked to a disruption in this drainage pathway: either a partial obstruction or complete occlusion of the iridocorneal angle impedes the egress of aqueous humor, resulting in its accumulation and a consequent elevation of intraocular pressure beyond physiological thresholds. Prolonged exposure to elevated pressure exerts deleterious effects on the optic nerve fibers, leading to progressive degeneration. In open-angle glaucoma—the most prevalent variant—this degenerative process advances insidiously, often remaining asymptomatic in its initial phases. While the precise etiopathogenesis of glaucoma has yet to be fully elucidated, multiple risk factors have been correlated with its development, including but not limited to: comorbid diabetes mellitus, genetic susceptibility, systemic hypertension, a history of migraine headaches, advanced age, and refractive errors such as myopia. Regardless of the presence of these predisposing factors, routine ophthalmologic screenings are strongly advised as a preventive measure. It is important to note that within many healthcare systems, including that of the United States, a referral from a primary care physician is typically required to access specialist evaluation. Patients are therefore encouraged to proactively discuss the necessity of such examinations with their general practitioner. Initiating treatment at a preclinical or early clinical stage significantly enhances the likelihood of preserving visual function and mitigating the risk of irreversible vision loss.

Glaucoma constitutes a chronic, progressive neurodegenerative disorder wherein untreated progression invariably leads to irreversible optic nerve damage and resultant visual field loss. The overarching therapeutic objective centers on preserving visual function through sustained reduction of intraocular pressure—the primary modifiable risk factor driving disease advancement. Initiation of intervention must occur promptly upon confirmation of diagnostic criteria, particularly when structural alterations of the optic nerve head are evident. First-line management predominantly employs topical pharmacotherapy, with non-selective and cardioselective β-adrenergic antagonists administered as ocular drops representing the cornerstone of conservative treatment. Clinical efficacy is critically dependent on patient adherence to precise instillation techniques; research indicates that over 60% of treatment failures stem from improper self-administration. In cases of refractory disease or absolute contraindications (e.g., chronic obstructive pulmonary disease, bradyarrhythmia), escalation to invasive procedures becomes necessary: laser trabeculoplasty (reserved for early-stage disease with minimal functional deficits) or microincisional drainage surgeries (recommended for advanced, rapidly progressive neuropathy). While dietary modifications demonstrate no direct capacity to arrest progression in established glaucoma, population-based studies suggest that antioxidant-rich diets (vitamins C and E, lutein) and omega-3 fatty acids may confer protective benefits by reducing the incidence of primary open-angle glaucoma among high-risk demographics.

Glaucoma may emerge as a severe complication of poorly managed type 2 diabetes mellitus or prolonged, untreated arterial hypertension, necessitating a comprehensive preventive strategy that integrates dietary modifications with systematic ophthalmological monitoring. At the core of this approach lies a metabolically optimized diet, the principles of which align with nutritional guidelines for both conditions. Sustaining euglycemia is paramount to mitigating the risk of microvascular complications—most notably diabetic neuropathy—which progressively damages neural fibers. Concurrently, excessive sodium intake, ubiquitous in contemporary diets, represents a modifiable risk factor for hypertensive disease, which in turn predisposes individuals to vascular alterations within the optic nerve. Therefore, conscious reduction of table salt is imperative, achieved through the elimination of post-preparation salting, substitution with flavorful herbal seasonings (such as cayenne pepper, turmeric, or fresh Provence herbs), and meticulous scrutiny of food labels for concealed sodium sources, including monosodium glutamate (E621), a common flavor enhancer. Priority should be given to avoiding ultra-processed, smoked, cured, or pickled products in favor of fresh, unprocessed protein sources (lean marine fish, poultry) and low-glycemic vegetables. In the context of glaucoma prevention, regular ophthalmologic evaluations are equally critical, with screening frequency tailored to individual risk profiles: healthy individuals should undergo tonometry and optic nerve head assessment every 24–36 months, whereas those with risk factors (including familial glaucoma history, diabetes, or migraine with aura) require annual examinations. Early detection of elevated intraocular pressure enables timely therapeutic interventions—pharmacological or surgical—that substantially reduce the likelihood of irreversible vision loss. Consistency in adhering to dietary and diagnostic recommendations thus constitutes the cornerstone of primary and secondary prevention for this condition, whose pathogenesis is intricately linked to modern civilization diseases, particularly metabolic dysfunction and cardiovascular dysregulation. The visual system, as the most sophisticated interface between humans and the universe (per M.H. Niżanowska’s observation), underscores the imperative of preserving ocular health through evidence-based preventive measures.